Feature | January 21, 2008| Cristen C. Bolan

Clock is Ticking for CTA

Just when you got excited about CT angiography (CTA) noninvasively diagnosing coronary artery disease, the Centers for Medicare and Medicaid Services (CMS) decided to slash reimbursement for CTA.

According to the CMS, "[t]he evidence is inadequate to conclude that cardiac computed tomographic angiography (CTA) is reasonable and necessary under section 1862(a)(1)(A) for the diagnosis of coronary artery disease (CAD)."
But wait, there is a silver lining. The CMS will reimburse for two CTA indications: for the diagnosis of CAD for symptomatic patients with chronic stable angina at intermediate risk of CAD; or symptomatic patients with unstable angina at a low risk of short-term death and intermediate risk of CAD. But this is only in cases where the patient is enrolled in a clinical trial for cardiac CT. Even patients who may have abnormal stress tests in low- or intermediate-risk populations are out of luck.

Many clinicians in the cardiac community argue that the CMS has not examined the full impact this proposal will have on the Medicare beneficiary, and have asked CMS to suspend its proposed National Coverage Decision (NCD) for two years to consider more studies published on coronary CTA.

Too late. Time's up. January 12, 2008 was the deadline to contribute to the CMS public comments forum. The final decision trumps all local coverage determinations for CTA already in place across all 50 states. Sorry asymptomatic patients - it's back to more costly and invasive procedures for you.

Related Content

Webinar | November 17, 2017
The CME webinar “Innovation and Success in 3D-inspired Development of the Business and Clinical Practice,” will take
HeartFlow's FFR-CT (FFRct) analysis software can create a virtual FFR to assess coronary artery disease.

HeartFlow's FFR-CT analysis software uses a computed tomography scan and supercomputing fluid dynamics software to create a noninvasive, virtual FFR map of the entire coronary artery tree to determine the flow-limiting severity of ant lesions. 

News | Cardiac Imaging| November 06, 2017
November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory P
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Medis Releases QAngio CT v3.1
Technology | Computed Tomography (CT)| October 09, 2017
Medis has released a new version of its QAngio CT (computed tomography), which can now be launched from the Medis Suite...
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
3D printing of the heart and coronary artery tree from a patient's CT scan.
Webinar | 3-D Printing| August 09, 2017
Learn how 3-D printing empowers medical device manufacturer Medtronic to bring products to market faster, develop bet
Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D
News | Interventional Radiology| August 03, 2017
Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and...
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Technologies| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Videos | CT Angiography (CTA)| July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Overlay Init